Document is current
Any future updates will be listed below
-
Authors
Dylan Hale, W.
Wang, Haobo https://orcid.org/0009-0003-3902-8326
Huganir, Richard L. https://orcid.org/0000-0001-9783-5183
Twomey, Edward C. https://orcid.org/0000-0002-1855-1586
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM154904)
Kinship Foundation (22098168)
Diana Helis Henry Medical Research Foundation (142548)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R37NS036715)
- License Information
-
More Information
Article History
Received: 21 November 2025
Accepted: 16 January 2026
First Online: 9 February 2026
Competing interests
: R.L.H. is a scientific cofounder and scientific advisory board (SAB) member of Neumora Therapeutics and an SAB member of MAZE Therapeutics. The other authors declare no competing interests.
